Search

Your search keyword '"Just M"' showing total 1,928 results

Search Constraints

Start Over You searched for: Author "Just M" Remove constraint Author: "Just M"
1,928 results on '"Just M"'

Search Results

1. Empirical estimates of the mutation rate for an alphabaculovirus.

2. Coevolution of hytrosaviruses and host immune responses

3. RNA interference-based antiviral immune response against the salivary gland hypertrophy virus in Glossina pallidipes

4. Enhancing vector refractoriness to trypanosome infection: achievements, challenges and perspectives

5. Hytrosavirus genetic diversity and eco-regional spread in Glossina species

6. Characterization and Tissue Tropism of Newly Identified Iflavirus and Negeviruses in Glossina morsitans morsitans Tsetse Flies

7. Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe

8. Expression Profile of Glossina pallidipes MicroRNAs During Symptomatic and Asymptomatic Infection With Glossina pallidipes Salivary Gland Hypertrophy Virus (Hytrosavirus)

9. Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus

10. Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA

11. Identification of Loci Associated with Enhanced Virulence in Spodoptera litura Nucleopolyhedrovirus Isolates Using Deep Sequencing

12. Virology, Epidemiology and Pathology of Glossina Hytrosavirus, and Its Control Prospects in Laboratory Colonies of the Tsetse Fly, Glossina pallidipes (Diptera; Glossinidae)

13. Comparative analysis of salivary gland proteomes of two Glossina species with differential hytrosavirus pathologies

14. West Nile Virus: High Transmission Rate in North-Western European Mosquitoes Indicates Its Epidemic Potential and Warrants Increased Surveillance.

15. Effective chikungunya virus-like particle vaccine produced in insect cells.

16. PHÁT HIỆN PROTEIN P74 TRÊN VI-RÚT GÂY BỆNH ĐỐM TRẮNG (WHITE SPOT SYNDROME VIRUS) Ở TÔM: PROTEIN TIỀM NĂNG TẠO VẮC-XIN

17. The salivary secretome of the tsetse fly Glossina pallidipes (Diptera: Glossinidae) infected by salivary gland hypertrophy virus.

18. Heterogeneous host susceptibility enhances prevalence of mixed-genotype micro-parasite infections.

19. Low temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formation.

20. Evolutionary trajectory of white spot syndrome virus (WSSV) genome shrinkage during spread in Asia.

23. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

25. The role of citizen science in addressing grand challenges in food and agriculture research

27. Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

29. 109P Updated long-term overall survival of older adjuvant ibandronate-treated patients with intermediate- or high-risk early breast cancer compared with additional adjuvant capecitabine treatment: The ICE randomized clinical trial

32. Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

37. 350MO Omission of chemotherapy and addition of the CDK4/6 inhibitor ribociclib in HER2-positive and hormone-receptor positive metastatic breast cancer – Second interim efficacy analysis of the randomized phase III DETECT V trial

39. LBA17 Survival outcome of neoadjuvant endocrine therapy + trastuzumab and pertuzumab (ET+T+P) vs. de-escalated chemotherapy (CT)+T+P in hormone receptor positive (HR+)/HER2+ early breast cancer (EBC): WSG-TP-II trial

46. Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)

47. White spot syndrome virus host range and impact on transmission

48. Updated list of QPS-recommended biological agents for safety risk assessments carried out by EFSA

49. Microbiological agents as notified to EFSA

50. 94P Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)

Catalog

Books, media, physical & digital resources